Matches in SemOpenAlex for { <https://semopenalex.org/work/W4231937390> ?p ?o ?g. }
Showing items 1 to 61 of
61
with 100 items per page.
- W4231937390 endingPage "S81" @default.
- W4231937390 startingPage "S81" @default.
- W4231937390 abstract "Levodopa-induced dyskinesia (LID) is a disabling motor complication occurring in Parkinson's disease patients (PD) after long-term l-DOPA treatment. Although its etiology remains unclear, there is accumulating evidence that LID relies on an excessive dopamine receptor transmission, particularly at the downstream signaling of D1 receptors. We previously reported that the pharmacological blockade of 5-alpha reductase (5AR), the rate limiting enzyme in neurosteroids synthesis, rescued a number of behavioral aberrations induced by D1 receptor-selective and non-selective agonists, without inducing extrapyramidal symptoms. Thus, the present study was designed to verify whether the 5AR inhibitor finasteride (FIN) may counteract the dyskinesias induced by dopaminergic agonists in 6-hydroxydopamine (6-OHDA)-lesioned rats. First, we assessed the acute and chronic effect of different doses of FIN (30–60 mg/kg) on LID, in male 6-OHDA-lesioned dyskinetic rats. Thereafter, to fully characterize the therapeutic potential of FIN on LID and its impact on l-DOPA efficacy, we assessed abnormal involuntary movements and forelimb use in hemiparkinsonian male rats chronically injected with FIN (30–60 mg/kg/24 days) either prior to- or concomitant with l-DOPA administration. In addition, to investigate whether the impact of FIN on LID may be ascribed to a modulation of the D1- or D2/D3-receptor function, dyskinesias were assessed in l-DOPA-primed 6-OHDA-lesioned rats that received FIN in combination with selective direct dopaminergic agonists. Finally, we set to investigate whether FIN may produce similar effect in female hemiparkinsonian rats, as seen in males.The results indicated that FIN administrations significantly dampened LID in all tested treatment regimens, without interfering with the ability of l-DOPA to ameliorate forelimb use in the stepping test. The antidyskinetic effect appears to be due to modulation of both D1- and D2/D3-receptor function, as FIN also reduced abnormal involuntary movements induced by the selective D1 receptor agonist SKF-82958 and the D2/D3 receptor agonist ropinirole. Significant dampening of LID was also observed in female rats, although only at the higher tested dose.Clinical investigations are warranted to assess whether similar protection from dyskinesia is seen in PD patients." @default.
- W4231937390 created "2022-05-12" @default.
- W4231937390 creator A5000790184 @default.
- W4231937390 creator A5027521362 @default.
- W4231937390 creator A5033382232 @default.
- W4231937390 creator A5090704081 @default.
- W4231937390 date "1997-01-01" @default.
- W4231937390 modified "2023-09-26" @default.
- W4231937390 title "Effects of APGW-AMID on [Ca] in rat pheochromocytoma PC12 cells" @default.
- W4231937390 doi "https://doi.org/10.1016/s0168-0102(97)81849-4" @default.
- W4231937390 hasPublicationYear "1997" @default.
- W4231937390 type Work @default.
- W4231937390 citedByCount "0" @default.
- W4231937390 crossrefType "journal-article" @default.
- W4231937390 hasAuthorship W4231937390A5000790184 @default.
- W4231937390 hasAuthorship W4231937390A5027521362 @default.
- W4231937390 hasAuthorship W4231937390A5033382232 @default.
- W4231937390 hasAuthorship W4231937390A5090704081 @default.
- W4231937390 hasConcept C126322002 @default.
- W4231937390 hasConcept C134018914 @default.
- W4231937390 hasConcept C137183658 @default.
- W4231937390 hasConcept C2777288102 @default.
- W4231937390 hasConcept C2779134260 @default.
- W4231937390 hasConcept C2779734285 @default.
- W4231937390 hasConcept C2780304432 @default.
- W4231937390 hasConcept C2780405171 @default.
- W4231937390 hasConcept C2780938664 @default.
- W4231937390 hasConcept C513476851 @default.
- W4231937390 hasConcept C71924100 @default.
- W4231937390 hasConcept C98274493 @default.
- W4231937390 hasConceptScore W4231937390C126322002 @default.
- W4231937390 hasConceptScore W4231937390C134018914 @default.
- W4231937390 hasConceptScore W4231937390C137183658 @default.
- W4231937390 hasConceptScore W4231937390C2777288102 @default.
- W4231937390 hasConceptScore W4231937390C2779134260 @default.
- W4231937390 hasConceptScore W4231937390C2779734285 @default.
- W4231937390 hasConceptScore W4231937390C2780304432 @default.
- W4231937390 hasConceptScore W4231937390C2780405171 @default.
- W4231937390 hasConceptScore W4231937390C2780938664 @default.
- W4231937390 hasConceptScore W4231937390C513476851 @default.
- W4231937390 hasConceptScore W4231937390C71924100 @default.
- W4231937390 hasConceptScore W4231937390C98274493 @default.
- W4231937390 hasLocation W42319373901 @default.
- W4231937390 hasOpenAccess W4231937390 @default.
- W4231937390 hasPrimaryLocation W42319373901 @default.
- W4231937390 hasRelatedWork W1979512025 @default.
- W4231937390 hasRelatedWork W2003088897 @default.
- W4231937390 hasRelatedWork W2029919306 @default.
- W4231937390 hasRelatedWork W2092105200 @default.
- W4231937390 hasRelatedWork W2501986330 @default.
- W4231937390 hasRelatedWork W2909115079 @default.
- W4231937390 hasRelatedWork W3174461003 @default.
- W4231937390 hasRelatedWork W3202665874 @default.
- W4231937390 hasRelatedWork W3205144601 @default.
- W4231937390 hasRelatedWork W914299022 @default.
- W4231937390 hasVolume "28" @default.
- W4231937390 isParatext "false" @default.
- W4231937390 isRetracted "false" @default.
- W4231937390 workType "article" @default.